Heilongjiang Zbd Pharmaceutical Co., Ltd. Class ASSE: 603567

"Heilongjiang ZBD Pharmaceutical Co., Ltd."Semi-annual Report for 2026

Aug 29, 2026 · Issued by Heilongjiang Zbd Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Heilongjiang Zbd Pharmaceutical Co., Ltd. Class A

"Heilongjiang ZBD Pharmaceutical Co., Ltd."Announcement on Change of Sponsor Representative for Continuous SupervisionAug 26
"Heilongjiang ZBD Pharmaceutical Co., Ltd."Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026Aug 19
"Heilongjiang ZBD Pharmaceutical Co., Ltd."Announcement on Progress of Provision of Guarantee for an Investee CompanyAug 14
"Heilongjiang ZBD Pharmaceutical Co., Ltd."Announcement on Provision of Guarantee Limit for Wholly-owned SubsidiaryJul 31

All Heilongjiang Zbd Pharmaceutical Co., Ltd. Class A news releases